These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Early pregnancy screening for neural tube defects in Israel. Legum C, Shomrat R, Yedwab G, Jaffa AJ, Rudick A. Isr J Med Sci; 1986 Dec; 22(3-4):210-4. PubMed ID: 2427475 [Abstract] [Full Text] [Related]
6. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus. Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, Qualls CR, Evans MI. Am J Med Genet; 1998 Jan 13; 75(2):176-8. PubMed ID: 9450880 [Abstract] [Full Text] [Related]
7. Triploidy identified through second-trimester serum screening. Huang T, Alberman E, Wald N, Summers AM. Prenat Diagn; 2005 Mar 13; 25(3):229-33. PubMed ID: 15791661 [Abstract] [Full Text] [Related]
8. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome. Benn PA, Craffey A, Horne D, Ramsdell L, Rodis JF. J Matern Fetal Med; 2000 Mar 13; 9(3):165-9. PubMed ID: 10914624 [Abstract] [Full Text] [Related]
9. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound. Dashe JS, Twickler DM, Santos-Ramos R, McIntire DD, Ramus RM. Am J Obstet Gynecol; 2006 Dec 13; 195(6):1623-8. PubMed ID: 16769022 [Abstract] [Full Text] [Related]
10. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients. Richards DS, Seeds JW, Katz VL, Lingley LH, Albright SG, Cefalo RC. Obstet Gynecol; 1988 Feb 13; 71(2):203-7. PubMed ID: 2447540 [Abstract] [Full Text] [Related]
11. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA. J Reprod Med; 1996 May 13; 41(5):327-32. PubMed ID: 8725757 [Abstract] [Full Text] [Related]
13. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice. Weiss BD. J Fam Pract; 1988 Mar 13; 26(3):273-80. PubMed ID: 2450166 [Abstract] [Full Text] [Related]
14. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience. Anfuso S, Soncini E, Bonelli P, Piantelli G, Gramellini D. Acta Biomed; 2007 Dec 13; 78(3):214-9. PubMed ID: 18330082 [Abstract] [Full Text] [Related]
15. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified. Widlund KF, Gottvall T. Acta Obstet Gynecol Scand; 2007 Dec 13; 86(2):167-71. PubMed ID: 17364279 [Abstract] [Full Text] [Related]
16. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination. CMAJ; 1994 Jul 15; 151(2):159-66. PubMed ID: 7518734 [Abstract] [Full Text] [Related]
17. Elevated maternal serum alpha-fetoprotein values. How low is high? Lenke RR, Guerrieri J, Nemes JM, Kurczynski TW, French B, Gray M, Schut H, Ashwood ER. J Reprod Med; 1989 Aug 15; 34(8):511-6. PubMed ID: 2478705 [Abstract] [Full Text] [Related]
18. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies. Candenas M, Villa R, Fernandez Collar R, Moina MJ, Pintado S, Garcia Saez F, Alvarez FV. Acta Obstet Gynecol Scand; 1995 Apr 15; 74(4):266-9. PubMed ID: 7537429 [Abstract] [Full Text] [Related]
20. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds? Roman AS, Gupta S, Fox NS, Saltzman D, Klauser CK, Rebarber A. Fetal Diagn Ther; 2015 Apr 15; 37(3):206-10. PubMed ID: 25034077 [Abstract] [Full Text] [Related] Page: [Next] [New Search]